Morning sickness and hormonal changes don’t just affect your stomach and mood – they can also take a toll on your teeth and ...

Women who use hormone therapy during menopause don’t have a higher risk of dying from cancer or cardiovascular disease than women who don’t, a new study shows.

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

From social media influencers to telehealth clinics, men are being told testosterone is the answer to all their problems. Doctors say it’s a dangerous lie.

Influencer Emily Hunt documented her experience of taking Mounjaro, highlighting significant weight loss and adverse reactions.  | Health ...

Now a fitness and lifestyle coach based in London, Reeves began testosterone replacement therapy (TRT) and says it has given ...

Postmenopausal women using hormone therapy and tirzepatide had greater weight loss and benefits for diastolic blood pressure and concentrations of triglycerides and aspartate aminotransferase than ...

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much ...

When it comes to getting older, there are certain things we take steps to prevent and others that we accept as unavoidable. Changes in estrogen levels, especially for women in perimenopause and ...

Brian is a New York–based science and health journalist. His work has been published by The Atlantic, The Paris Review, The New York Times For Kids, CBS News, The TODAY Show, Barron's PENTA, Engadget, ...

Bencivenga is the special projects manager at PharmedOut, a rational prescribing project at Georgetown University Medical Center. Fugh-Berman is a professor at GUMC and director of PharmedOut. If ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen treatment for women with breast cancer, a new Cambridge-led trial has found. A low ...